Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOBEC3G Antikörper (N-Term)

Zitiert in 5+ Publikationen. Der Kaninchen Polyklonal anti-APOBEC3G Antikörper (ABIN965574) detektiert spezifisch APOBEC3G in IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN965574
603,63 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mg
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für APOBEC3G Antikörper (N-Term) (ABIN965574)

Target

Alle APOBEC3G Antikörper anzeigen
APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))

Reaktivität

  • 80
  • 4
  • 3
  • 2
Human

Wirt

  • 73
  • 6
  • 1
Kaninchen

Klonalität

  • 77
  • 3
Polyklonal

Konjugat

  • 36
  • 7
  • 6
  • 6
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser APOBEC3G Antikörper ist unkonjugiert

Applikation

  • 68
  • 38
  • 28
  • 13
  • 13
  • 11
  • 9
  • 3
  • 3
  • 2
  • 2
Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 15
    • 9
    • 9
    • 8
    • 7
    • 6
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Immunogen

    Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to N-terminal residues of human APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G)
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Lagerung

    4 °C
  • Pido-Lopez, Jeffrey, Wang, Seidl, Babaahmady, Vaughan, Lehner: "The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity." in: European journal of immunology, Vol. 39, Issue 7, pp. 1956-65, (2009) (PubMed).

    Chen, He, Wang, Xu, Yu: "A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G." in: Journal of virology, Vol. 83, Issue 17, pp. 8674-82, (2009) (PubMed).

    Dang, Wang, Zhou, York, Zheng: "Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization." in: Journal of virology, Vol. 83, Issue 17, pp. 8544-52, (2009) (PubMed).

    Vetter, DAquila: "Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells." in: Journal of virology, Vol. 83, Issue 17, pp. 8646-54, (2009) (PubMed).

    Kamada, Igarashi, Martin, Khamsri, Hatcho, Yamashita, Fujita, Uchiyama, Adachi: "Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 45, pp. 16959-64, (2006) (PubMed).

  • Target

    APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))

    Andere Bezeichnung

    APOBEC3G

    Hintergrund

    APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3G) is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. APOBEC3G is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. APOBEC3G has been found to be a specific inhibitor of human immunodeficiency virus-1 (HIV-1) infectivity.
Sie sind hier:
Chat with us!